Dans cette 21e baladodiffusion, le Dr Luc Lanthier discute du traitement des patients avec hypertriglycéridémie à haut risque cardiovasculaire avec des oméga-3 (étude REDUCE-IT), en plus de réviser la littérature médicale de novembre 2018.
Quiz clinique (1min10), étude principale (1min40), critique (17min05), autres articles (25min10), réponse au quiz clinique (32min22)
Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, et al.
Cardiovascular
Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med.
2018. doi: 10.1056/NEJMoa1812792. PubMed PMID: 30415628.
Kastelein JJP, Stroes ESG. FISHing for the
Miracle of Eicosapentaenoic Acid. N Engl J Med. 2018 Nov 16. doi:
10.1056/NEJMe1814004. PubMed PMID: 30444682
Group ASC, Bowman L, Mafham M, Wallendszus K, Stevens W, Buck G, et al.
Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus. N Engl J Med.
2018;379(16):1540-50. PubMed PMID: 30146932.
Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, et al. Marine
n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer. N Engl J Med. 2018. doi:
10.1056/NEJMoa1811403. PubMed PMID: 30415637.
Siscovick DS, Barringer TA, Fretts AM, Wu JH, Lichtenstein AH, Costello
RB, et al. Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and
the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the
American Heart Association. Circulation. 2017;135(15):e867-e84. PubMed PMID: 28289069.
Aung T, Halsey J, Kromhout D, et al. Associations of
omega-3 fatty acid supplement use with cardiovascular disease risks:
meta-analysis of 10 trials involving 77 917 individuals. JAMA Cardiol. 2018;3(3):225-34.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003177.pub3/full
Autres articles d’intérêt
PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, et al. Alirocumab and Cardiovascular
Outcomes after Acute Coronary Syndrome. N Engl J Med. 2018;379(22):2097-107. PubMed PMID: 30403574.
Bohula EA, Scirica BM, Inzucchi SE, McGuire DK, Keech AC,
Smith SR, et al; CAMELLIA-TIMI 61 Steering Committee Investigators. Effect of
lorcaserin on prevention and remission of type 2 diabetes in overweight and
obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial. Lancet. 2018 Nov
24;392(10161):2269-2279. PubMed PMID: 30293771.
Dehghan M, Mente A, Rangarajan S, Sheridan P,
Mohan V, Iqbal R, et al. Association of dairy intake with cardiovascular
disease and mortality in 21 countries from five continents (PURE): a
prospective cohort study. Lancet. 2018;392(10161):2288-2297. PubMed PMID: 30217460.
Hernandez AF, Green JB, Janmohamed S, D’Agostino RB Sr, Granger
CB, Jones NP,
et al. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes
and cardiovascular disease (Harmony Outcomes): a double-blind, randomised
placebo-controlled trial. Lancet. 2018;392(10157):1519-1529. PubMed PMID: 30291013.
Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, et al.
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med.
2018. doi: 10.1056/NEJMoa1812389. PubMed PMID: 30415602.
Rosenstock J, Perkovic V,
Johansen OE, Cooper ME, Kahn SE, Marx N, et al. Effect of Linagliptin vs Placebo
on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular
and Renal Risk: The CARMELINA Randomized Clinical Trial. JAMA. 2018. doi: 10.1001/jama.2018.18269.
Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, Bonaca MP, et
al. SGLT2
inhibitors for primary and secondary prevention of cardiovascular and renal
outcomes in type 2 diabetes: a systematic review and meta-analysis of
cardiovascular outcome trials. Lancet. 2018. pii: S0140-6736(18)32590-X. doi:
10.1016/S0140-6736(18)32590-X. PubMed PMID: 30424892.
Chang HY, Singh S, Mansour O, Baksh S, Alexander GC. Association Between
Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among
Patients With Type 2 Diabetes. JAMA Intern Med. 2018;178(9):1190-8. PubMed PMID: 30105373.
Ueda P, Svanstrom H, Melbye M, Eliasson B, Svensson AM, Franzen S, et
al. Sodium glucose cotransporter 2 inhibitors and risk of serious adverse
events: nationwide register based cohort study. BMJ. 2018;363:k4365. doi:
10.1136/bmj.k4365. PubMed PMID: 30429124.
Carbone S, Dixon DL, Buckley LF, Abbate A. Glucose-Lowering Therapies
for Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: State-of-the-Art
Review. Mayo Clin Proc. 2018;93(11):1629-47. PubMed PMID: 30392544.
Andrade JG, Verma A, Mitchell LB, Parkash R, Leblanc K,
Atzema C, et al. 2018 Focused Update of the Canadian Cardiovascular Society
Guidelines for the Management of Atrial Fibrillation. Can J Cardiol. 2018;34(11):1371-92. PubMed PMID:
Panel A-IHG. Hepatitis C Guidance 2018 Update: AASLD-IDSA
Recommendations for Testing, Managing, and Treating Hepatitis C Virus
Infection. Clin Infect Dis. 2018;67(10):1477-92. PubMed PMID: 30215672.
Carey RM, Calhoun DA, Bakris GL, Brook RD, Daugherty SL,
Dennison-Himmelfarb CR, et al. Resistant Hypertension: Detection, Evaluation,
and Management: A Scientific Statement From the American Heart Association.
Hypertension. 2018;72(5):e53-e90. PubMed PMID: 30354828.
Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; Executive Group on behalf
of the Joint European Society of Cardiology (ESC)/American College of
Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF)
Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal
Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018 Oct 30;72(18):2231-2264.
R, Clark NP, Ansell J, Holbrook A, Skov J, et al. American Society of Hematology
2018 guidelines for management of venous thromboembolism: optimal management of
anticoagulation therapy. Blood Adv. 2018 Nov 27;2(22):3257-3291. PubMed PMID: 30482765.
HJ, Cushman M, Burnett AE, Kahn SR, Beyer-Westendorf J, Spencer FA, et al. American Society of
Hematology 2018 guidelines for management of venous thromboembolism:
prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv. 2018 Nov
27;2(22):3198-3225. PubMed PMID: 30482763.
GM, Chong BH, Cines DB, Greinacher A, Gruel Y, Linkins LA, Rodner SB, Selleng
S, Warkentin TE, Wex A, Mustafa RA, Morgan RL, Santesso N. American Society of
Hematology 2018 guidelines for management of venous thromboembolism:
heparin-induced thrombocytopenia. Blood Adv. 2018 Nov 27;2(22):3360-3392. PubMed PMID: 30482768.
Bates SM, Righini M, Haramati LB, Lang E, Kline JA, Chasteen S, Snyder M, Patel
P, Bhatt M, Patel P, Braun C, Begum H, Wiercioch W, Schünemann HJ, Mustafa RA. American Society of
Hematology 2018 guidelines for management of venous thromboembolism: diagnosis
of venous thromboembolism. Blood Adv. 2018 Nov 27;2(22):3226-3256. PubMed PMID: 30482764.
Référence du quiz clinique
Ling E, Howell S, Vang M, Aronowitz P. Man’s best friend, fatal in the
end. Cleve Clin J Med. 2017;84(2):146-50. PubMed PMID: 28198689.
Solverson KJ, Doig CJ. A fatal case of pneumococcal sepsis years after
splenectomy. CMAJ.
2017;189(23):E800-E2. PubMed PMID: 28606976.